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Abstract
ING2 (inhibitor of growth family, member 2) is a member of the plant homeodomain (PHD)-containing ING family of
putative tumor suppressors. As part of mSin3A-HDAC corepressor complexes, ING2 binds to tri-methylated lysine 4 of
histone H3 (H3K4me3) to regulate chromatin modification and gene expression. ING2 also functionally interacts with the
tumor suppressor protein p53 to regulate cellular senescence, apoptosis and DNA damage response in vitro, and is thus
expected to modulate carcinogenesis and aging. Here we investigate the developmental and physiological functions of
Ing2 through targeted germline disruption. Consistent with its abundant expression in mouse and human testes, male mice
deficient for Ing2 showed abnormal spermatogenesis and were infertile. Numbers of mature sperm and sperm motility were
significantly reduced in Ing2
2/2 mice (,2% of wild type, P,0.0001 and ,10% of wild type, P,0.0001, respectively). Their
testes showed degeneration of seminiferous tubules, meiotic arrest before pachytene stage with incomplete meiotic
recombination, induction of p53, and enhanced apoptosis. This phenotype was only partially abrogated by concomitant
loss of p53 in the germline. The arrested spermatocytes in Ing2
2/2 testes were characterized by lack of specific HDAC1
accumulation and deregulated chromatin acetylation. The role of Ing2 in germ cell maturation may extend to human ING2
as well. Using publicly available gene expression datasets, low expression of ING2 was found in teratozoospermic sperm
(.3-fold reduction) and in testes from patients with defective spermatogenesis (.7-fold reduction in Sertoli-cell only
Syndrome). This study establishes ING2 as a novel regulator of spermatogenesis functioning through both p53- and
chromatin-mediated mechanisms, suggests that an HDAC1/ING2/H3K4me3-regulated, stage-specific coordination of
chromatin modifications is essential to normal spermatogenesis, and provides an animal model to study idiopathic and
iatrogenic infertility in men. In addition, a bona fide tumor suppressive role of Ing2 is demonstrated by increased incidence
of soft-tissue sarcomas in Ing2
2/2 mice.
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Introduction
ING2 (inhibitor of growth family, member 2) plays pivotal roles
in the regulation of cellular senescence, apoptosis, DNA damage
repair, gene transcription and chromatin modification [1,2]. Our
previous in vitro studies on cellular senescence suggested that ING2
functionally interplays with the p53 tumor suppressor protein in
two different manners: endogenous ING2 inhibits senescence and
the transcriptional repression of ING2 by p53 abrogates this
inhibition [3]; and overexpressed ING2 enhances p53 acetylation
and stability to induce senescence [4,5]. ING2, as a subunit of the
mSin3A-HDAC1 (histone deacetylase 1) complex, specifically
binds to tri-methylated lysine 4 of histone H3 (H3K4me3) via its
plant homeodomain (PHD) finger and regulates gene expression
through chromatin modifications in response to DNA damage
[6,7]. Although these findings imply that ING2 may contribute in
vivo to p53-regulated processes, as well as developmental and
homeostatic processes involving chromatin regulation, the in vivo
physiological roles of ING2 have not been experimentally
examined.
Spermatogenesis, a series of spermatogenic cell differentiation
steps from spermatogonia to mature spermatozoa in the testes, is a
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15541process tightly regulated by chromatin modifications [8,9].
Enzymes that modify histone methylation, including Meisetz (an
H3K4 tri-methyltransferase) [10], G9a [a mono- and di-
methyltransferase on lysine 9 of histone H3 (H3K9)] [11], and
Suv39h1 and Suv39h2 (H3K9 tri-methyltransferases) [12], are
essential for normal germ cell development in mice. The stage-
specific acetylation profiles of several lysine residues on core
histones, i.e., acetylation in spermatogonia and deacetylation
during differentiation from leptotene to pachytene stages, are also
critical to normal spermatogenesis in mice [8,13]. Consistently,
HDAC inhibitors impaired male fertility in mice through loss of
pachytene spermatocytes and increased apoptosis [14,15,16]. Such
dynamic regulation of chromatin modifications during spermato-
genesis is not limited to mice: the H3K4 methylation profiles
during spermatogenesis were very similar between mice and non-
human primates [17]. Misregulated histone acetylation is
associated with defective spermatogenesis in humans [18],
suggesting that chromatin-mediated regulation is a conserved
mechanism from rodents to humans. However, no specific gene
defect has been identified in humans as responsible for
spermatogenic defect due to aberrant chromatin regulation [19].
In this study, our generation and characterization of Ing2-
deficient mice reveal that ING2 plays an essential in vivo role in
mammalian spermatogenesis, which is attributed to its functional
interaction with p53 and chromatin regulation. The relevance in
humans is underscored by bioinformatics analysis revealing low
ING2 expression in men with infertility and defective spermato-
genesis. In addition, loss of Ing2 resulted in high incidence of soft-
tissue sarcomas, particularly histiocytic sarcomas, demonstrating,
for the first time, a tumor suppressor role for Ing2.
Results
ING2 is expressed abundantly in mouse and human
testes
Quantitative RT-PCR (qRT-PCR) analysis of Ing2 mRNA
expression in normal mouse tissues demonstrated a tissue-specific
expression pattern, with testis showing the highest level of Ing2
(Fig. 1A), as has been reported in humans [20]. Immunohisto-
chemical (IHC) staining of human testis sections showed that the
cells in seminiferous tubules expressed higher levels of ING2
protein than the interstitial cells (Fig. 1B, Fig. S1). These data
indicate that germ cells are the major source of ING2 expression
in mouse and human testes.
Generation of Ing2-deficient mice
To examine the in vivo developmental and physiological roles of
ING2, with particular interest to testicular development and
function, mouse Ing2 gene was knocked out using a Cre-loxP
recombination system (Fig. S2A). DNA genotyping (Fig. S2B),
qRT-PCR analysis (Fig. S2C) and western blot analysis (Fig. S2D)
confirmed the generation of mice with wild-type Ing2 (+/+),
heterozygous for Ing2 knockout (+/2) and homozygous for Ing2
knockout (2/2). In crosses between heterozygous mice, the
occurrences of Ing2
+/+, Ing2
+/2 and Ing2
2/2 genotypes were 27%
(154 out of 570), 56% (319 out of 570) and 17% (97 out of 570),
respectively, showing a slight deviation from the expected
Mendelian distribution and indicating that Ing2 deficiency may
have a mild adverse effect on embryonic or prenatal development.
Ing2-deficient males are infertile
The postnatal growth of Ing2
2/2 mice was indistinguishable
from that of their Ing2
+/+ littermates. Ing2
2/2 mice had
significantly smaller testes than those of Ing2
+/+ mice throughout
their life (Fig. 1C,D and Table 1, P,0.001), but did not show any
gross abnormalities in other organs, including seminal vesicles,
epididymides and vasa deferens (Fig. 1C, Table 1). The small-sized
testes of Ing2
2/2 mice were not due to serum testosterone levels
(Table 1).
When 8-week-old Ing2
+/+, Ing2
+/2 and Ing2
2/2 mice were
mated, Ing2
2/2 male mice were revealed to be infertile, while
Ing2
+/2 male and Ing2
2/2 female mice were fertile. The number
of normal sperm found in semen from epididymis and vas deferens
in 8-week-old Ing2
2/2 males was only approximately 2% of that in
age-matched Ing2
+/+ control (Fig. 1E, F and Table 1, P,0.0001).
The low sperm count in Ing2
2/2 mice became more severe with
aging (Fig. 1F). In Ing2
2/2 mice, the sperm motility was also
severely impaired (Table 1, P,0.0001) and almost all spermatozoa
showed abnormal morphologies, such as round heads, short tails,
large heads, multiple tails and tail coiling (Fig. 1G). Thus, male
infertility in Ing2
2/2 mice is attributed to quantitative and
qualitative defects in mature spermatozoa.
Ing2
2/2 testes show degeneration of seminiferous
tubules
Histological analysis showed normal germ cell development in
seminiferous tubules in Ing2
+/+ testes (Fig. 2A,B). In contrast,
Ing2
2/2 testes exhibited seminiferous tubule degeneration, germ
cell under-population (Fig. 2C,D) with Leydig cell hyperplasia,
apoptotic cells and multinucleated giant cells (Fig. 2E). In Ing2
2/2
seminiferous tubules, spermatogonia are present in low numbers
and in some tubules various developmental stages can be seen up to
round spermatid. The major cell stage observed in these tubules is
spermatocyte with large dense nuclei (Fig. 2D, 2B, black arrows).
However, postmeiotic cell types such as round and elongated
spermatids (Fig. 2B, white allow) were scarcely observed in Ing2
2/2
tubules (Fig. 2D), suggesting a spermatogenesis arrest at meiotic
phase in most tubules. Observation of the epididymal wall also
suggests that the cellular organization of this structure is also
compromised in Ing2
2/2 mice. While mature spermatozoa were
present in the epididymides of Ing2
+/+ mice, hypospermia was
observed in Ing2
2/2 (Fig. 2F).
Ing2
+/+ and Ing2
2/2 testes were histologically examined
throughout the mouse lifespan (Fig. S3). While Ing2
+/+ seminifer-
ous tubules developed normally and became completely populated
with all stages of germ cells by 6 to 8 weeks, most Ing2
2/2 tubules
remained devoid of germ cells and/or disorganized at the same
age. Analysis at 6 through 24 months of age reveals that Ing2
+/+
tubules maintained normal germ cell development. Ing2
2/2
tubules, however, underwent progressive degeneration and germ
cell depletion, eventually showing a Sertoli-cell-only pathology at
24 months. When the epididymis was examined at 24 months,
mature spermatozoa were present in Ing2
+/+, while the Ing2
2/2
epididymis displayed an aspermic phenotype.
Meiotic arrest and impaired meiotic recombination in
Ing2
2/2 testes
DNA contents were analyzed in cells from 2- and 6-month-old
Ing2
+/+ and Ing2
2/2 testes (Fig. 2G). Ing2
2/2 testes showed
reduced 1N fractions (representing round and elongated sperma-
tids) at 2 months of age, which were almost absent at 6 months. A
relative increase in 2N fractions (spermatogonia and somatic cells)
in Ing2
2/2 testes can be attributed to a failure to complete meiosis
II as well as to the presence of somatic cells associated with Leydig
cell hyperplasia and Sertoli-cell-only tubules in degenerated
seminiferous tubules. An apparent loss of 4N fractions (spermato-
cytes) in Ing2
2/2 testes became evident at 6 months that can be
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PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15541Figure 1. Testicular atrophy and semen abnormalities in Ing2
2/2 mice. (A) ING2 is abundant in testes. qRT-PCR analysis of ING2 expression in
mouse tissues. ING2 expression levels (normalized to GAPDH) are shown on a scale of 10
24. (B) Immunohistochemical (IHC) staining of ING2 protein
in a normal human testis section. Positive nuclear staining is evident in the seminiferous tubule. Scale bar is 100 mm. (C) Morphology of reproductive
organs from 8-week-old Ing2
+/+ and Ing2
2/2 male mice. The seminal vesicles (black arrowheads), bladder (white arrows), epididymis (white
arrowheads), testes (black arrows) are demonstrated. Scale bar, 1 cm. (D) Testis weight during postnatal development of Ing2
+/+ and Ing2
2/2 mice.
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PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15541attributed to premature loss of germ cells with ageing. Immuno-
histochemical (IHC) staining of phosphorylated histone H2AX (c-
H2AX) marked DNA double-strand breaks at leptotene stage
associated with meiotic recombination [21,22] in both Ing2
+/+ and
Ing2
2/2 testes [Fig. 2H-K; black arrows in (I) and (K)]. The c-
H2AX signals were diminished at pachytene stage in Ing2
+/+
seminiferous tubules [Fig. 2H,I; white arrows in (I)], as normally
expected with the completion of meiotic recombination [21,22]. In
contrast, Ing2
2/2 seminiferous tubules were defective in progres-
sion to the c-H2AX-negative pachytene stage (Fig. 2J,K) and
instead contained spermatocytes with abnormally accumulated c-
H2AX (Fig. 2K, white arrowheads). These results are consistent
with the histopathological observations described above, and
indicate a failure to complete meiosis, as well as a progressive loss
of germ cells with aging in Ing2
2/2 mice.
Gene expression profiles in Ing2
2/2 testes are consistent
with spermatogenesis arrest
Gene expression profiling by mRNA microarray analysis using
whole testis RNA identified 619 genes differentially expressed (381
downregulated and 238 upregulated, P,0.001, FDR,0.04) in
Ing2
2/2 testes compared with Ing2
+/+ testes (GSE18610 at http://
www.ncbi.nlm.nih.gov/geo/). Ing2 was the most downregulated
gene (Table S1), confirming the validity of the experimental
system. A genelist consisting of genes differentially expressed in
Ing2
2/2 testes was used to query a database of gene expression
profiles during mouse spermatogenesis, including spermatogonia,
spermatocytes and spermatids, as well as Sertoli cells, whole
seminiferous tubules, and whole testes [GermOnline, http://www.
germonline.org [23]]. There was a significant correlation (non-
parametric Spearman correlation P,0.0001) between gene
expression in Ing2
2/2 testes and gene expression during mouse
spermatogenesis. Specifically, genes differentially expressed in
Ing2
2/2 testes were positively correlated with genes expressed in
Sertoli cells (Spearman r=0.72 and spermatogonia (Spearman
r=0.70), but negatively correlated with genes expressed in
spermatocytes (Spearman r=20.25) and spermatids (Spearman
r=20.74). These expression profiles further validate the conclu-
sions from our histopathological and IHC findings that indicate
failed differentiation of spermatocytes as the major defect caused
by Ing2 deficiency.
Table 1. Weight of organs, serum testosterone levels, and sperm parameters in Ing2
+/+ and Ing2
2/2 male mice.
Ing2
+/+ Ing2
2/2 P value
a
Total body weight (g)
b 25.964.0 23.661.4 NS
Organ Weight (mg)
b,c Brain 321610.8 31268.6 NS
Thymus 79.2630.1 59.666.8 NS
Lung 86.166.3 76.1614.6 NS
Heart 153616.9 143637.7 NS
Spleen 103619.8 79.467.7 NS
Kidney 192627.3 167612.9 NS
Liver 15396432 13536176 NS
Stomach 234632.3 221677.4 NS
Intestine, pancreas, mesenterium 23036248 20276448 NS
Seminal vesicle 105619.4 83.1611 NS
Bladder and prostate 132622.7 108619.0 NS
Epididymis 19.562.6 17.967.1 NS
Testis 91.8613.6 45.2611.2 0.0004
Serum testosterone (ng/dl)
d 8 wks 88.6622 135648 NS
26 wks 66.4617 44.8619 NS
Sperm parameters
e Total no. of cells(x10
6) 44.465.8 9.861.7 0.005
No. of normal sperm (x10
6)3 2 67.5 0.760.2 ,0.0001
Sperm motility (%) 91.064.3 11.463.2 ,0.0001
aStudent’s t test, NS; Not significant.
b8-week-old mice were examined. n=5 per group. Values are means 6 SD.
cThe wet weights of paired organs were averaged for each mouse, and this single value was used to calculate mean 6 SD among same genotype.
dn=5 per group. Values are means 6 SD.
en=3 per group. Values are means 6 SD.
doi:10.1371/journal.pone.0015541.t001
Student’s t test, n=5 per group. Error bars are s.e.m. (E) Semen in Ing2
+/+ and Ing2
2/2 mice. Scale bars, 100 mm. (F) Numbers of normal spermatozoa
in semen during postnatal development of Ing2
+/+ and Ing2
2/2 mice. Data are mean from n=3 (8 weeks) or n=2 (16 and 24 weeks). Error bars are
s.e.m. (G) Normal and abnormal spermatozoa from Ing2
+/+ and Ing2
2/2 mice, respectively. The leftmost panel (Ing2
+/+) shows mature normal
spermatozoon with a characteristic, hook-shaped nucleus, straight mitochondrial sheath and straight tail. The right three panels (Ing2
2/2) show
morphologically abnormal, immature spermatozoa, including ones with a round head and a short tail (black arrow), a large head and multiple tails
(white arrow), and a tail coiled (white arrowhead). Scale bars are 50 mm in the left three panels and 25 mm in the rightmost panel.
doi:10.1371/journal.pone.0015541.g001
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e15541Figure 2. Degeneration of seminiferous tubules and meiotic arrest in Ing2
2/2 testes. (A–E) Histological analysis of testis sections from 8-
week-old Ing2
+/+ (A, B) and Ing2
2/2 (C–E) mice by hematoxylin and eosin (H&E) staining. Black arrows in (B) and (D) indicate spermatocytes with large,
condenced nuclei. The white arrow in (B) indicates spermatids, which are missing in (D). In (E), Leydig cell hyperplasia (white arrows), apoptotic cell
(black arrow) and multinucleated giant cell (white arrowhead) are indicated. Scale bars are 200 mm in (A) and (C), 100 mm in (B), (D) and (E, left), and
50 mm in (E, right). (F) Histological analysis of epididymis from 8-week-old Ing2
+/+ and Ing2
2/2 mice by H&E staining. Scale bars, 100 mm. Black arrows
indicate degenerated round cells in Ing2
2/2 epididymis. (G) Flow cytometric analysis of testis cells isolated from 2- and 6-month-old Ing2
+/+ and
ING2 Fosters Spermatogenesis and Tumor Suppression
PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15541Downregulation of genes encoding spermatogenesis-
related proteins and chromatin regulatory factors in
Ing2
2/2 testes
A subset of differentially expressed genes identified by
microarray analysis that have well-characterized roles in
spermatogenesis and chromatin regulation is listed in Table S1.
A group of genes involved in normal differentiation and function
of spermatids or sperms, including Prss21 [24], Sly [25], Spef2
[26], Ssty2 [27] and the Speer family of testis-specific genes [28],
were downregulated in Ing2
2/2 testes, consistent with impaired
progression to these later stages of male germ cell development.
Two downregulated genes, Asb4 (ankyrin repeat and SOCS box-
containing protein 4) [29] and Gzmn (granzyme N) [30], are
believed to be specifically involved in spermatocyte differentia-
tion at pachytene stage, when Ing2 deficiency manifested its
effect. The marked downregulation of these two genes in Ing2
2/2
testes was validated by qRT-PCR (Fig. S4). It should also be
noted that several genes encoding chromatin modifying or
associated proteins, including Setdb2 [31], Zfp57 [32], Suv39h2
[12], Satb2 [33], Ing3 [34] and Phf21a [35], were downregulated
in Ing2
2/2 testes. In addition to the deregulation of chromatin
modifications by loss of Ing2 itself, decreased expression of these
proteins may possibly affect chromatin status and contribute to
defective spermatogenesis in Ing2
2/2 testes. A set of somatic cell-
derived transcripts upregulated in testes of HDAC inhibitor-
treated mice [14] were notsignificantly changed in Ing2
2/2 testes
(Table S2).
Aberrant chromatin modifications in Ing2
2/2 testes
The amounts of H3K4me3, HDAC1 and mSin3A, which all
functionally interact with ING2 to regulate chromatin modifica-
tion [6,7], were found to be abundant in the testes in Ing2
+/+ mice
( F i g .S 5 ) .I nI H Cs t a i n i n g ,b o t hIng2
+/+ and Ing2
2/2 testes
contained HDAC1-negative spermatogonia and leptotene sper-
matocytes (Fig. 3A, leftmost panels; black arrows). HDAC1 was
induced during spermatocyte differentiation into pachytene stage
inIng2
+/+ testes (Fig. 3A,leftmost panel;white arrow).In contrast,
spermatocytes in Ing2
2/2 testes showed no significant HDAC1
staining (Fig. 3A, leftmost panel; white arrowheads), consistent
with the impaired differentiation to the pachytene stage. Total
amounts of HDAC1 were also shown to be decreased in Ing2
2/2
testes by Western blot (Fig. 3B,C). Three acetylation sites on core
histones (H3K18, H4K8 and H4K12) were acetylated in
spermatogonia and leptotene spermatocytes in both Ing2
+/+ and
Ing2
2/2 testes (Fig. 3A, right three panels each; black arrows). In
Ing2
+/+ testes, the deacetylation of these lysine residues was
coincident with HDAC1 induction (Fig. 3A, right three panels;
white arrows). In contrast, lack of HDAC1 induction in Ing2
2/2
seminiferous tubules resulted in accumulated spermatocytes with
these sites highly acetylated (Fig. 3A, right three panels; white
arrowheads). These results suggest that the meiotic arrest before
pachytene stage due to Ing2 deficiency is associated with
impaired accumulation of HDAC1 and deregulated histone
acetylation.
p53-dependent and independent apoptosis in Ing2
2/2
testes
Because of the functional association of ING2 with p53 and the
well-characterized role of p53 in regulating apoptosis in the testis
[36,37,38], we next explored the effect of Ing2 deficiency on p53
expression. To this end, 8-week-old Ing2
+/+ and Ing2
2/2 testes, as
well as p53
2/2 testes as a negative control, were examined for p53
protein expression. A ,2.5-fold increase in p53 protein was
observed in whole testis lysates of Ing2
2/2 mice compared to age-
matched Ing2
+/+ mice (Fig. 4A,B). Immunohistochemical analysis
of p53 protein revealed intratubular staining only in germ cells of
Ing2
2/2 testes, but not Ing2
+/+ or p53
2/2 testes (Fig. 4C). No
significant increase in p53 mRNA level was found in Ing2
2/2
testes (Fig.4D) suggestive of a post-transcriptional mechanism for
p53 induction. PUMA, a p53-induced apoptosis effector, was also
upregulated in luminal regions of the tubules in Ing2
2/2 testes
(Fig. S6). These results indicate that endogenous ING2 promotes
germ cell survival and differentiation. Loss of ING2 leads to p53
activation in vivo, perhaps as an indirect result of testicular
degeneration or through a novel regulatory interaction between
p53 and ING2.
To better characterize the tubular degeneration brought about
by Ing2 deficiency, we determined the presence of apoptotic or
senescent germ cells in testes at 8 weeks of age. We found that
Ing2
2/2 testes had significantly increased numbers of TUNEL-
positive tubules and TUNEL-positive cells per tubule, compared
with those in age-matched Ing2
+/+ testes (Fig. 5A, left two bars in
both panels). While apoptotic germ cells were observed rarely
and close to the basement membrane in Ing2
+/+ testes (Fig. 5B,
Ing2
+/+), they occurred frequently in spermatocytes in luminal
regions of the tubules (Fig. 5B, Ing2
2/2). Neither Ing2
+/+ nor
Ing2
2/2 testes at 8 week of age showed positive staining for
senescence-associated b-galactosidase, a marker of cellular senes-
cence [39], in their seminiferous tubules (data not shown).
We next investigated whether disruption of p53 would rescue
defective spermatogenesis and enhanced apoptosis of Ing2
2/2
mice. Although spermatocytes in p53
2/2 males may have an
impaired DNA damage response, leading to the formation of a
multinucleated giant cell [37,40], they show otherwise normal
spermatogenesis and are fertile [41] (Fig. 5C, p53
2/2), allowing
us to generate p53/Ing2 double-knockout mice. Ing2 deficiency in
a p53
2/2 background reproduced the abnormalities observed in
t h ep r e s e n c eo fp53, including reduced testis weight (Fig. 5D),
degeneration of seminiferous tubules, hypospermia in epididy-
mides, reduced numbers of normal spermatozoa in semen
(Fig. 5C, p53
2/2Ing2
2/2) and enhanced apoptosis (Fig. 5A,
right two bars in both panels; Fig. 5B, p53
2/2 and p53
2/2
Ing2
2/2). However, these abnormalities in p53
2/2Ing2
2/2 males
were less severe than those in Ing2
2/2 males as mentioned above.
Quantitative data analysis of the TUNEL assay showed that
p53
2/2Ing2
2/2 testes had higher levels of apoptosis than Ing2
+/+
and p53
2/2 testes but lower levels of apoptosis than Ing2
2/2
testes (Fig. 5A), suggesting that Ing2 deficiency induces apop-
tosis in a p53-dependent manner, which is consistent with
p53 induction in Ing2
2/2 testes (Fig. 4), as well as in a p53-
Ing2
2/2 mice. The flow cytograms (left) demonstrate three peaks; 1N peak representing round and elongated spermatids, 2N peak representing
somatic cells, spermatogonia and secondary spermatocytes, and 4N peak representing primary spermatocytes, including leptotene, zygotene and
pachytene stages. The data are shown as percentage of 1N, 2N and 4N cell fractions (right). (H–K) Phosphorylated histone H2AX (c-H2AX) staining in
testes from 8-week-old Ing2
+/+ (H, I) and Ing2
2/2 (J, K) mice. Normal leptotene and zygotene spermatocytes with positive c-H2AX staining [black
arrows in (I) and (K)] develop into pachytene spermatocytes in Ing2
+/+ testes [white arrows in (I)], which have a c-H2AX focus corresponding to the sex
body but are otherwise negative for c-H2AX staining [21]. In Ing2
2/2 testes, c-H2AX-positive, abnormal spermatocytes accumulate [white arrowheads
in (K)] without development into pachytene spermatocytes. Scale bars are 100 mm in (H) and (J), and 50 mm in (I) and (K).
doi:10.1371/journal.pone.0015541.g002
ING2 Fosters Spermatogenesis and Tumor Suppression
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15541independent manner. Thus, p53 deficiency partially rescued the
pathological changes due to Ing2 deficiency. Nevertheless, degen-
erated large, round cells were accumulated in p53
2/2Ing2
2/2
epididymis and semen (Fig. 5C; black arrows), and p53
2/2Ing2
2/2
males were still infertile.
Reduced ING2 expression is associated with impaired
spermatogenesis and male infertility in humans
To examine the expression of ING2 in men with low sperm
count, morphologically abnormal sperm and/or impaired sper-
matogenesis, public microarray datasets available at GEO (http://
www.ncbi.nlm.nih.gov/geo) and ArrayExpress (http://www.ebi.
ac.uk/microarray-as/ae) were queried using the Nextbio search
engine (http://www.nextbio.com) (Table 2). Two datasets
(GSE6967 and GSE6872) comparing spermatozoa purified from
semen samples of infertile teratozoospermic men versus normal
fertile men [42] showed significantly lower levels of ING2
expression in the former cases. In two independent studies
comparing testicular biopsies with impaired spermatogenesis
classified according to Johnsen score [43] versus full spermatogen-
esis (GSE4797 and five comparisons in E-TABM-234) [44,45],
decreased expression of ING2 was consistently associated with the
spermatogenic defect. Furthermore, ING2 expression was lower in
testicular biopsy specimens from non-obstructive azoospermia
(NOA) patients than those from obstructive azoospermia (OA)
patients (GSE9210) [46], suggesting the functional involvement of
reduced expression of ING2 in human male infertility due to
defective germ cell development, but not that due to a physical
obstruction. Considering that germ cells are the major source of
ING2 expression in testis, the finding of low ING2 expression in
men with Sertoli-cell only syndrome likely reflects the fact that the
spermatogenic cell types are absent from the seminiferous tubules.
This association does not per se indicate a causative role for ING2
deficiency in human male infertility.
Figure 3. Impaired HDAC1 expression and altered histone acetylation in Ing2
2/2 testes. (A) HDAC1, histone H3 acetylated at lysine 18
(acetyl-H3K18), histone H4 acetylated at lysine 8 (acetyl-H4K8) and histone H4 acetylated at lysine 12 (acetyl-H4K12) staining in testes from 8-week-
old Ing2
+/+ and Ing2
2/2 mice. Black arrows indicate spermatogonia and leptotene spermatocytes in both Ing2
+/+ and Ing2
2/2 testes. White arrows
indicate normal pachytene spermatocytes showing HDAC1 induction (leftmost panel) and histone deacetylation (right three panels) in Ing2
+/+ testes.
White arrowheads indicate abnormal spermatocytes without HDAC1 induction (leftmost panel) and with sustained histone acetylation (right three
panels) in Ing2
2/2 testes. Scale bars, 50 mm. (B–C) Reduced expression of HDAC1 in Ing2
2/2 testes. Whole testis lysates from 8-week-old Ing2
+/+ and
Ing2
2/2 mice (4 mice each) were examined in western blot using anti-HDAC1 antibody. b-actin was a loading control. Relative HDAC1 expression
levels (normalized to b-actin) based on quantitative image analysis are shown in (B) and in (C). *P,0.001. Student’s t test, n=4 per group. Error bars
are s.e.m.
doi:10.1371/journal.pone.0015541.g003
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2/2 testes. (A–B) Western blot analysis of p53 protein expression using whole testis lysates from Ing2
+/+ and
Ing2
2/2 testes, as well as p53
2/2 testes (negative control), at 8 weeks of age. b-actin was a loading control. Relative p53 expression levels (normalized
to b-actin) based on quantitative image analysis are shown in (A) and in (B). Student’s t test. n=3 per group. Error bars are s.e.m. (C) p53 staining in
testes from 8-week-old p53
2/2, Ing2
+/+ and Ing2
2/2 mice. Black arrows indicate intratubular positive staining in Ing2
2/2 testes. Both Ing2
+/+ and
Ing2
2/2 testes, as well as p53
2/2 testes to a much lesser extent, show interstitial staining (white arrowheads). Scale bars, 100 mm. (D) Real-time qRT-
PCR analysis of p53 mRNA expression. Two independent primers/probe sets (assays 1 and 2) were used. The expression levels in Ing2
2/2 testes are
shown as the relative values to those in Ing2
+/+ testes. Data are mean 6 s.e.m. from n=8 (Ing2
+/+)o rn = 1 4( Ing2
2/2). No statistically significant
difference was observed (Student’s t test).
doi:10.1371/journal.pone.0015541.g004
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PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e15541Figure 5. Increased apoptosis and defective spermatogenesis in testes by Ing2 deficiency in the absence of p53. (A, B) TUNEL assay in
testes from 8-week-old Ing2
+/+, Ing2
2/2, p53
2/2 and p53
2/2Ing2
2/2 mice. (A) The data are shown as ratios of TUNEL-positive tubules to total tubules
examined (left) and as average numbers of TUNEL-positive cells per a TUNEL-positive tubule (right). At least 50 tubules were examined in each group.
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To examine whether Ing2 deficiency affects tumorigenesis and
the aging processes, we observed Ing2
+/+ (n=22) and Ing2
2/2
(n=28) mice for two years. There was no statistically significant
difference in survival between the two genotypes (Fig. S7, P=0.43,
Log-rank test). However, detailed histopathological analysis of
both groups at time of death showed a significant change in
malignant tumor spectrum. The incidence of soft tissue sarcomas
was increased in Ing2
2/2 mice (P=0.017) (Table 3). The major
tumor type observed in Ing2
2/2 mice was histiocytic sarcoma (Fig.
S8, Table 3), which showed increased incidence preferentially in
males for currently unknown reasons (Table S3). Although we
confirmed significantly increased frequencies of degenerated
seminiferous tubules and oligozoospermic epididymis in Ing2
2/2
mice (Tables S4 and S5), pathological examinations of other
organs and tissues showed that Ing2
2/2 mice had no remarkable
difference from Ing2
+/+ mice in the spectrum of non-malignant
lesions, except for increases in benign harderian gland adenomas
and in atypical lymphoid hyperplasia of the spleen and a decrease
in acinar dilation in prostate (Table S4). Ing2
2/2 mice also showed
no signs of premature aging, such as hair graying, alopecia, skin
atrophy, lordokyphosis, osteoporosis or cataracts. Thus, we
currently conclude that Ing2 deficiency by itself does not affect
aging phenotypes but enhances spontaneous formation of soft-
tissue sarcomas.
Discussion
This study provides evidence that ING2 is an essential regulator
of mammalian spermatogenesis by showing that: 1) testes express
high levels of ING2 (Fig. 1A,B, Fig. S1); 2) genetic knockout of Ing2
causes a spermatogenesis defect and male infertility in mice
(Figs 1C–G, 2A–F and Table 1); and 3) decreased ING2
expression is highly associated with defective spermatogenesis
and male infertility in humans (Table 2). The data indicate that the
spermatogenic function of ING2 depends on both its regulatory
effect on chromatin (Fig. 3) as well as its functional interaction with
p53 (Fig. 4,5).
The spermatocytes in defective Ing2
2/2 seminiferous tubules
underwent meiotic arrest (Fig. 2G), which was also observed in
mouse models deficient for histone methyltransferases [10,11,12].
However, unlike these mouse models in which fertility was
impaired in both male and female, Ing2 deficiency only affected
male fertility, suggesting a distinct role for ING2 in regulating
chromatin modification during mammalian germ cell develop-
ment. Histopathologically, the blocked differentiation of Ing2
2/2
spermatocytes into pachytene stage (Fig. 2H–K,5A) most resem-
bled the meiotic defect in testes in mice treated with a HDAC1
inhibitor, trichostatin-A [15]. The ability of ING2 to recruit
HDAC1 to H3K4me3 [6], the dynamic regulation of H3K4me3
during zygotene-to-pachytene progression [17], and the accumu-
lation of HDAC1 and the deacetylation of core histones in
pachytene spermatocytes in Ing2
+/+ but not Ing2
2/2 mouse testes
(Fig. 3A) all suggest that the spermatogenesis defect by Ing2
deficiency is due to a disturbance of the stage-specific histone
modifications coordinated by the H3K4me3-ING2-HDAC1
interaction. Our data establish ING2 as a chromatin-associated,
non-enzyme protein that is critical to temporal and spatial profiles
of chromatin modifications during spermatogenesis. A recent
study provides further support to this hypothesis. Suberoylanilide
hydroxamic acid (SAHA), an HDAC inhibitor used clinically for
the treatment of cancer causes the dissociation of ING2 from the
Sin3 deacetylase complex leading to de-repression of downstream
genes and growth inhibition[47]. Our findings reveal a plausible
mechanism by which HDAC inhibitors may disrupt deacetylase
function during spermatogenesis, through disruption of Ing2-
bound co-repressor complexes. Consistent with this is also the
finding that mice deficient on the Sirt1 protein deacetylase show
spermatogenesis defects similar to Ing2-deficient mice [48]. SIRT1
is recruited by ING proteins to negatively regulate mSIN3A/
Table 2. ING2 expression in spermatogenic pathologies in humans.
Dataset ID (ref) Specimen Control group Test group Fold change
a P value
b
GSE6967 (42) Sperm Normal Teratozoospermic 267.4 0.0008
GSE6872 (42) Sperm Normal Teratozoospermic 23.20 2.4e-5
GSE4797 (44) Testicular biopsies Full spermatogenesis Sertoli-cell-only syndrome
c 27.75 0.0112
E-TABM-234 (45) Testicular biopsies Full spermatogenesis Johnsen score 2
d 21.52 0.0025
Johnsen score 3.2
d 21.70 0.0006
Johnsen score 5
d 21.62 0.0012
Johnsen score 7
d 21.45 0.0052
Johnsen score 8
d 21.32 0.0267
GSE9210 (46) Testicular biopsies Obstructive Azoospermia Non-obstructive Azoospermia 21.34 0.0009
alog2 ratio (Test group/Control group).
bWelch’s t test.
cEquivalent to Johnsen score 2.
dJohnsen score 2: no germ cells, Sertoli cells only; Johnsen score 3.2: Sertoli cells and few spermatogonia; Johnsen score 5: no spermatids, many spermatocytes; Johnsen
score 7: no late spermatids, many early spermatids; Johnsen score 8: few late spermatids.
doi:10.1371/journal.pone.0015541.t002
*P,0.001, which corresponds to P,0.05 after applying the stringent Bonferroni correction for 9 multiple comparisons. Student’s t test, n=4 per
group. Error bars are s.e.m. (B) Representative pictures are shown. Black arrows indicate examples of TUNEL-positive cells. Scale bars, 100 mm. (C)
Histological analysis of testes (top, scale bars, 100 mm.), epididymis (middle, scale bars, 50 mm.) and semen (bottom, scale bars, 100 mm.) from 8-week-
old p53
2/2 and p53
2/2Ing2
2/2 mice. Black arrows indicate degenerated large, round cells in p53
2/2Ing2
2/2 epididymis and semen. (D) Average
weight of testis from 8-week-old Ing2
+/+, Ing2
2/2, p53
2/2 and p53
2/2Ing2
2/2 mice. *P,0.001. Student’s t test, n=5 per group. Error bars are s.e.m.
doi:10.1371/journal.pone.0015541.g005
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whether an altered expression of one or a few specific genes or a
genome-wide change in chromatin status mediates the defects in
Ing2-deficient mice, as well as in other infertile mice deficient for
chromatin modifying factors. The two pachytene-specific genes
identified in this study, Asb4 and Gzmn (Fig. S4), deserve further
investigation. The somatic cell-derived transcripts differentially
expressed in testes of trichostatin-A-treated mice [14] were not
significantly affected by Ing2 deficiency (Table S2), in agreement
with the findings that germ cells are the major cell type expressing
ING2 (Fig. 1B, Fig. S1). Ing2-deficient mice should thus be a
suitable model to study germ cell-autonomous effects of chromatin
modifications on spermatogenesis.
Ing2
2/2 mice exhibited phenotypic differences from mice
deficient for Ing1, the founder member of the ING family, which
could be explained by the difference in organ-specific expression
profiles [20], the different interacting proteins [1], the different
modes of functional interaction with p53 [50], and/or the different
p53-independent functions [51]. ING1 expression was low in testes
[20] and Ing1-deficient mice were fertile [51,52]. Whereas Ing1
2/2
mice had reduced body size [52], Ing2
2/2 mice grew normally.
Furthermore, while Ing1
2/2 mice had elevated incidence of B-cell
lymphomas [51,52], Ing2
2/2 mice had elevated incidence of
histiocytic sarcoma (Table 3,S3). p19
Arf-deficient mice exhibit
similar phenotypes to Ing2
2/2 mice, such as testicular atrophy,
increased germ cell apoptosis, loss of sperm and high incidence of
histiocytic sarcoma [53,54]. This most intriguing finding brings up
the possibility that ING2 and p19
Arf, two p53 regulatory proteins,
are involved in a common pathway that is aimed to restrict self-
renewal and ensure normal differentiation during spermatogenesis
as well as prevent tumor development.
p53 regulates apoptosis in testes, which eliminates germ cells
with DNA damage induced by irradiation [36,37]or spontaneously
occurring during normal spermatogenesis [38]. p53-independent
apoptosis also occurs during spermatogenesis in response to DNA
damage and meiotic arrest [37,55]. Our comparative analysis of
apoptosis in Ing2
+/+, Ing2
2/2, p53
2/2 and p53
2/2Ing2
2/2 testes
(Fig. 5A,B) indicates that both p53-dependent and independent
mechanisms of apoptosis were activated by Ing2 deficiency,
probably contributing to the elimination of developmentally
arrested spermatocytes with unprocessed DNA lesions (Fig. 2J,K).
The induction of p53 by Ing2 deficiency (Fig. 4) suggests that a
physiological in vivo function of endogenous ING2 may be to
prevent an illegitimate activation of p53 under non-stressed
conditions. However, this functional link between ING2 and p53
is not a sole mechanism by which ING2 ensures normal
spermatogenesis and male fertility, as indicated by the mitigated
but still significant pathological changes in testes (Fig. 5C,D), the
accumulation of abnormal spermatozoa (Fig. 5C) and infertility in
p53
2/2Ing2
2/2 males.
Approximately 10% of couples suffer from infertility with
approximately equal contributions from men and women [56].
Meiotic arrest during spermatogenesis, as observed in Ing2
2/2
mice, is frequently associated with male infertility in humans [57].
However, because of the complexity of the spermatogenic process
possibly involving thousands of different genes, a majority of male
infertility cases in humans remain not understood [19]. Given a
disturbed pattern of chromatin modification in defective sper-
matogenesis in humans [18] and decreased ING2 expression
commonly associated with sperm abnormalities and pathological
changes in spermatogenesis in humans (Table 2), we propose that
the ING2-mediated chromatin regulation is critical to normal
meiotic progression during spermatogenesis in humans as well and
may be widely, if not universally, impaired by a number of
different spermatogenic defects leading to idiopathic infertility in
men. Genetic and epigenetic changes, as well as functional
Table 3. Malignant tumors arising in aging study.
Ing2
+/+ (n=22)
a Ing2
2/2 (n=28)
b P value
c
Soft-tissue sarcomas 3/22 (14%) 13/28 (46%) 0.017
Histiocytic sarcoma 1 8
Hemangiosarcoma 1 2
Leiomyosarcoma 1 0
Sarcoma, NOS
d 02
Neurofibrosarcoma 0 1
Lymphomas 4/22 (18%) 2/28 (7%) NS
Follicular B-cell lymphoma 2 2
Splenic marginal zone B-cell lymphoma 2 0
Carcinomas 7/22 (32%) 8/28 (29%) NS
Lung 6 3
Duodenum 1 0
Ovary 0 2
Liver 0 1
Pancreas 0 1
Thyroid 0 1
Osteosarcomas 0/22 (0%) 0/28 (0%) NS
a10 female and 12 male.
b11 female and 17 male.
cFisher’s exact test, NS; Not significant.
dNot otherwise specified.
doi:10.1371/journal.pone.0015541.t003
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infertile men.
This study also has significant implications in infertility in men
with other diseases, in particular malignant tumors. Patients with
testicular cancers are frequently infertile [58,59], with the
degeneration of peritumoral, non-cancerous seminiferous tubules
[18,58]. HDAC inhibitors are under clinical trial in patients with
various types of solid and hematologic malignancies [60,61].
Spermatogenesis is a process highly sensitive to DNA damage by
common chemotherapy and radiotherapy [58,62] and male
infertility is a major quality-of-life issue in cancer survivors
[58,63]. We expect that the Ing2
2/2 mice generated and
characterized in this study can be a model system to study
idiopathic and iatrogenic male infertility in humans.
Materials and Methods
Generation of Ing2
2/2 mice
This mice study was approved by the ACUC, NCI-Frederick
and all the guidelines were followed for the study. To construct the
targeting vector for Ing2, a BAC clone containing the Ing2 locus
was isolated from a 129-mouse genomic library (Genome Systems
Inc, St.Louis, MO). A 6.2-kilobase (kb) HindIII–HindIII fragment
encompassing from the first intron to the second intron was cloned
into the HindIII site of the pBS-SK(-)Pst(-) vector, pBluescript SK(-)
(Stratagene, La Jolla, CA) with PstI site removed. A 1.7-kb
HindIII–HindIII fragment within the second intron was cloned into
the HindIII site of the pLoxpneo vector (a gift from Dr. Chuxia
Deng) [64]. A single loxp site was inserted into the PstI site at the
first intron within the 6.2-kb fragment cloned in the pBS-SK(-)
Pst(-). The resulting plasmid was cleaved with NotI and XhoI and
inserted into the NotI and XhoI sites of the pLoxpneo containing
the 1.7-kb fragment. The final targeting construct was designated
pLoxpneoIng2 (Fig. S1a). The targeting construct was linearized
and electroporated into ES cells derived from 129/Sv mice. G418-
resistant colonies were selected and expanded. The ES clones with
correct targeting events were identified by Southern blot and
PCR. Heterozygous mice with the targeted allele (Ing2
flox2neo/+)
were crossed with each other, resulting in homozygous mice
(Ing2
flox2neo/flox2neo). These homozygous mice were crossed with
EIIa-Cre[65] mice to remove DNA fragments between two loxp
sites. This led to the generation of three types of offspring with a
deletion of the neomycin resistance cassette (Ing2
+/flox), the exon 2
(Ing2
+/neo), or both (Ing2
+/2). The identified Ing2
+/2 mice were
then bred with C57BL/6J mice to segregate the EIIa-Cre
transgene. Ing2
+/2 mice without EIIa-Cre were mated with each
other, leading to the generation of Ing2 knockout mice (Ing2
2/2).
To genotype mice, genomic DNAs were extracted from tails
using REDExtract-N-Amp Tissue PCR kit (Sigma, St. Louis, MO)
andanalyzedbyPCR.Thermalcyclingwascarried outfor35cycles
of denaturation at 94 Cu for 30 s, annealing at 55 Cu for 30 s and
extension at 72 Cu for 1 min. The primers were as follows: Ing2-F1
(59-actgcctcagagcagcaatccca-39) commonly used for Ing2
+ and Ing2
2
loci, Ing2-R1 (59-ttgccacatagtcatgaggacc-39) for amplifying 118-bp
product from Ing2
+ locus, and Ing2-R3 (59-gatctctgtcacacagtatg-39)
for amplifying 158-bp product from Ing2
2 locus.
p53-deficient mice were previously described [41]. p53 and Ing2
double knockout mice (p53
2/2Ing2
2/2) were generated as
previously described by Hussain et al [66] for p53 and NOS2
double knockout mice.
Quantitative real-time RT-PCR
Total RNAs were extracted from the whole testes of 8-week-old
mice using Trizol (Invitrogen, Carlsbad, CA) according to the
manufacturer’s protocol. Five micrograms of total RNA were used
for the synthesis of first strand cDNA using the SuperScript III
First Strand cDNA Synthesis Kit (Invitrogen). To examine ING2
expression in various mouse organs, BD MTC Mouse Panel III
was purchased from BD Biosciences (San Jose, CA). Real-
time RT-PCR analysis was performed using ABI prism 7900
(Applied Biosystems, Foster City, CA) with Taqman Gene
Expression Assays, purchased from Applied Biosystems; Ing2
(Mm00469833_m1), p53 (Mm00441964_g1, assay 1 in this
study), p53 (Mm01337166-mH, assay 2 in this study), Asb4
(Mm00480830_m1), and Gzmn (Mm00461850_m1). GAPDH
(Applied Biosystems, Mm99999915_g1) was used as internal
control. Normalized or relative gene expression was calculated
using the equation 2
2DCt or 2
2DDCt, respectively, where
DCt=Ct(Gene)2Ct(GAPDH).
Gross anatomical and histological examinations
Gross examination of organ weight and morphology on all mice
necropsied at 2 weeks to 2 years of age. For routine histopath-
ological examination all tissues were formalin-fixed, embedded in
paraffin, sectioned at 5 mm and stained with hematoxylin and
eosin (H&E).
Western blotting
Testes and other organs were removed from 8-week-old mice.
Mouse embryo fibroblasts were prepared by standard procedures.
For Western blotting, tissues and cells were lysed in RIPA buffer
(150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 1 mM
EDTA, 0.1% SDS, 10 mM Tris-HCl, pH 7.5) containing
complete protease inhibitors (Roche, Indianapolis, IN). Protein
samples were run on SDS-polyacrylamide gels (4–20% gradient)
(Invitrogen) and blotted onto 0.45-mm nitrocellulose membranes
(Bio-Rad Laboratories, Hercules, CA). Membranes were blocked
with 5% skim milk in Tris-buffered saline before incubation with
primary antibodies: anti-HDAC1 (Millipore, Billerica, MA), anti-
H3K4me3 (Abcam, Cambridge, MA), anti-mSin3A (Santa Cruz
Biotechnology, Santa Cruz, CA), anti-PUMA (Novus Biologicals
Inc), anti-p53 (Santa Cruz Biotechnology, and anti-ING2 [68].
Signals were detected according to standard procedures using
ECL detection (Amersham Pharmacia Biotech, Piscataway, NJ).
Quantitative image analysis of relative protein expression levels
was performed using ImageJ 1.40 g software (http://rsb.info.nih.
gov/ij/).
Immunohistochemical Staining (IHC)
For IHC, testes were fixed in formalin. Antigen retrieval and
immunochemical staining were performed as previously described
[67] using EnVision System-HRP (DAB) (Dako Cytomation,
Carpinteria, CA). Antibodies used for IHC were as follows: anti-
AcH3K18 (Cell Signaling Technology, Danvers, MA), anti-
AcH4K8 (Cell Signaling Technology), anti-AcH4K12 (Cell
Signaling Technology), anti-c-H2AX (Novus Biologicals Inc,
Littleton, CO), anti-HDAC1 (Millipore), anti-p53 (Novocastra,
Bannockburn, IL) and anti-ING2 (Sigma).
TUNEL assay
For terminal deoxynucleotidyltransferase-mediated dUTP-bio-
tin nick end labeling (TUNEL) analysis, formalin-fixed sections
were deparaffinized, rehydrated, and pretreated with proteinase
K. Apoptotic cells were detected using DeadEnd Colorimetric
TUNEL system kit (Promega, Madison, WI) according to the
manufacturer’s instructions.
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For each mouse (8-, 16- and 24-week-old) whole epididymis and
vas deferens were harvested, cut into 2-mm-long pieces,
resuspended in 1 ml of buffer containing 75 mM NaCl, 24 mM
EDTA and 0.4% bovine serum albumin. Pieces and sperm fluid
were homogenized at 32uC for 10 min to dissociate somatic cells.
Sperm cells remaining as a monodispersed suspension were
counted on a hemocytometer.
Testosterone assay
Blood was taken from 8- and 26-week-old male mice (five in
each group) that were being housed singly, in separate cages.
Female mice were being housed in separate cages of the same
room at the time of blood sampling. Serum testosterone level was
measured using ELISA kit (Alpha Diagnostic International, San
Antonio, TX) according to the manufacturer’s instructions.
Flow cytometry
Testes were excised from 2- and 6-month-old mice (three mice
in each group), decapsulated and crushed through 20-gauge
needles and 70-mm cell strainers (BD Biosciences) in phosphate-
buffered saline. Cells (2610
6) were treated with RNase and stained
with propidium iodide using a Cycle Test Plus DNA reagent kit
(Becton Dickinson, Franklin Lakes, NJ). All fluorescence-activated
cell sorting data were analyzed using CELL Quest (version 3.3;
Becton Dickinson).
mRNA microarray analysis
Total RNA samples were isolated from whole testes of Ing2
+/+
(n=3) and Ing2
2/2 (n=5) mice at 2-3 months of age using Trizol
(Invitrogen). Microarray analysis was performed using Affymetrix
platform (Mouse Gene 1.0 ST Array). Data was RMA-normalized
using Affymetrix Expression Console, annotated according to
NetAffx release: 28 (2009-03-16) and summarized at the gene
level. Resulting normalized and annotated probesets were
imported into BRB Array Tools (http://linus.nci.nih.gov/BRB-
ArrayTools.html). A Class Comparison analysis, based on a Two-
sample T-test using the random variance model, yielded 1046
probesets differentially expressed between Ing2
+/+ and Ing2
2/2
testes (P,0.001, FDR,0.04). Of those, 300 were not associated
with a named gene and were excluded from further analysis. After
further filtering for multiple occurrences of a gene ID, 619 unique
genes remained, of which 381 were downregulated and 238 were
upregulated.
Bioinformatics analyses
To determine a cell type-specific expression of ING2 in mouse
testis, ING2 expression values were extracted from the public
Gene Expression Omnibus data repository (GEO, http://www.
ncbi.nlm.nih.gov/geo/). A microarray dataset of testes from
C57BL/6 mice (accession number GDS409) was interrogated.
The expression values for ING2 probesets were identified within
the normalized data files available at GEO, and they were
subsequently plotted to generate graphical displays.
To examine whether ING2 expression levels are associated with
spermatogenic defects and male infertility in humans, we used the
datasets available at GEO and ArrayExpress (http://www.ebi.ac.
uk/microarray-as/ae), which encompass microarray analysis of
testes from men with low sperm count, morphologically abnormal
sperm and/or impaired spermatogenesis. Meta-analysis was
performed using the Nextbio database of curated and processed
high-throughput data (http://www.nextbio.com) by querying for
the search term ‘‘ING2’’ and filtering for ‘‘male infertility’’ or
‘‘azoospermia’’. The analysis output consisted of individual
microarray study results that showed differential ING2 expression
for the tested comparisons in each dataset. For each microarray
study, the fold change and p-value of ING2 for the comparison
were indicated.
To compare between the existing datasets of spermatogenesis-
associated profiles of gene expression and the differentially
expressed genes identified by the mRNA microarray analysis in
this study, the gene symbols were compiled into two genesets:
upregulated (238) or downregulated (381) in Ing2
2/2 testes. These
genesets were separately uploaded to GermOnline (http://www.
germonline.org [23]), a database of microarray expression
profiling data from experiments relevant for the mitotic and
meiotic cell cycle, gametogenesis and fertility, from which
corresponding expression values were extracted. Expression
intensities of 98 and 138 genes were extracted from the
upregulated and downregulated genesets, respectively. Expression
intensities in Sertoli cells, spermatogonia, spermatocytes, sperma-
tids and tubules were normalized to total testis and plotted
separately for each geneset.
Analysis of spontaneous tumors
Life span and spontaneous tumor incidence were determined in
Ing2
+/+ and Ing2
2/2 mice. Mice with visible tumors and moribund
mice showing weight loss or difficulties in moving were sacrificed
upon detection. The remaining surviving mice were sacrificed at
24 months of age. Gross anatomical and histological examinations
were performed as described above.
Human subjects
The histology of Mouse testis was compared with human testis
obtained from the Armed Forces Institute of Pathology at Water
Reed Army Medical Center (AFIP). Use of the human organs was
approved by the NIH Office of Human Subjects Research
(OHSR) which issued an IRB Exemption (#4545) for the study.
Immunohistochemical (IHC) staining of ING2 protein in a normal
human testis section was done at the AFIP at Water Reed Army
Medical Center.
Supporting Information
Figure S1 IHC staining of ING2 in normal human testis.
The rectangular area in (A) is enlarged in the (B). Scale bars are
200 mm in (A) and 100 mm in (B). The specimens in this figure and
in Fig.1B were obtained from different individuals. (TIF)
Figure S2 Generation of Ing2
2/2 mice. (A) Schematic
representation of the targeting vector (pLoxpneoIng2), the wild-
type Ing2 locus and the targeted locus. Ing2 exon 1, Ing2 exon 2 and
neomycin-resistant gene cassette (TA/neo) are shown as boxes.
Red triangles indicate loxP sites. Cleavage sites by HindIII, NotI,
XbaI and XhoI are also shown. See METHODS for details. (B)
DNA genotyping by PCR. (C) Real-time quantitative RT-PCR
analysis of ING2 mRNA expression in 8-week-old mouse testes.
n=3 per group. ING2 expression levels (normalized to GAPDH)
are shown on a scale of 10
24. (D) Western blot analysis of ING2
protein expression in mouse embryo fibroblasts. (TIF)
Figure S3 Histological analysis of testes from Ing2
+/+
and Ing2
2/2 mice at different ages. Testes (T) at 2 weeks to
24 months of age, as well as epididymis (E) at 24 months of age,
were examined by H&E staining. Scale bars, 200 mm. (TIF)
Figure S4 Real-time qRT-PCR analysis of Asb4 and
Gzmn mRNA expressions. The expression levels in Ing2
2/2
testes are shown as the relative values to those in Ing2
+/+ testes.
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+/+)o rn=1 4( Ing2
2/2).
*P,0.01, **P,0.001, Student’s t test. (TIF)
Figure S5 Western blot analysis of H3K4me3, HDAC1
and mSin3A levels in various organs from 8-week-old
Ing2
+/+ mice. b-actin was a loading control. (TIF)
Figure S6 Immunohistochemical staining of PUMA
protein. Testis sections from 8-week-old Ing2
+/+ and Ing2
2/2
mice were used. Spermatogonias with positive PUMA staining
[black arrows] were observed in both Ing2
+/+ and Ing2
2/2 testes.
Abnormal spermatocytes were PUMA-positive in Ing2
2/2 testes
(white arrowheads). Scale bars, 100 mm. (TIF)
Figure S7 Kaplan-Meier survival curves of Ing2
+/+
(n=22) and Ing2
2/2 (n=28) mice. P=0.43, Log-rank test.
Figure S8 Representative images of histiocytic sarcoma
of liver and lung in Ing2
2/2 mice. Scale bars are 100 mm (left
panels) and 50 mm (right panels). (TIF)
Table S1 Selected genes differentially expressed in Ing2
2/2
testes. (DOC)
Table S2 Somatic cell-derived transcripts upregulated by
trichostatin-A treatment were not significantly changed in Ing2
2/2
testes. (DOC)
Table S3 Histiocytic sarcoma arising in aging study. (DOC)
Table S4 Incidence of non-malignant lesions in aging study.
(DOC)
Table S5 Degeneration of seminiferous tubules in aging study.
(DOC)
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